U.S. markets closed

Revlon, Inc. (REV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
7.99-0.39 (-4.65%)
At close: 04:00PM EDT
7.89 -0.10 (-1.25%)
After hours: 07:03PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Intermediate-term KST

Intermediate-term KST

Previous Close8.38
Bid7.89 x 1000
Ask7.95 x 800
Day's Range7.53 - 8.59
52 Week Range1.08 - 17.65
Avg. Volume18,410,172
Market Cap435.764M
Beta (5Y Monthly)2.12
PE Ratio (TTM)N/A
EPS (TTM)-3.29
Earnings DateNov 03, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for REV

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Revlon, Inc. New
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total revenue is generated in the United States.
    Fair Value
    Economic Moat
    23 hours agoMorningstar
View more
  • The Wall Street Journal

    Revlon Names Interim CFO Amid Bankruptcy Process

    Revlon is changing out its top finance executive roughly two months after filing for bankruptcy protection. Revlon, owner of brands including Elizabeth Arden, Juicy Couture and Cutex, said current CFO is retiring after more than four years in the role. The change in finance leadership comes as Revlon’s stock price has rallied in recent weeks, leading shareholders to press for more say in the bankruptcy process.

  • Business Wire

    Revlon Announces Changes in Finance Leadership

    NEW YORK, August 09, 2022--Revlon, Inc. (NYSE: REV) ("Revlon" or the "Company") today announced that Victoria Dolan is retiring as the Company’s Chief Financial Officer ("CFO"). Ms. Dolan will remain with Revlon until September 30, 2022 to ensure a smooth transition of her responsibilities.

  • Business Wire

    Revlon Reports Second Quarter 2022 Results

    NEW YORK, August 09, 2022--Revlon, Inc. (NYSE: REV) ("Revlon" and together with its subsidiaries, the "Company") today announced its results for the quarter ended June 30, 2022, in its Form 10-Q filed with the Securities and Exchange Commission (the "SEC"). During the quarter, the Company commenced a voluntary Chapter 11 financial restructuring supported by $575 million of new money debtor-in-possession financing. Due to the pending Chapter 11 cases, the Company will not host an earnings call th